JP2007506434A5 - - Google Patents

Download PDF

Info

Publication number
JP2007506434A5
JP2007506434A5 JP2006528260A JP2006528260A JP2007506434A5 JP 2007506434 A5 JP2007506434 A5 JP 2007506434A5 JP 2006528260 A JP2006528260 A JP 2006528260A JP 2006528260 A JP2006528260 A JP 2006528260A JP 2007506434 A5 JP2007506434 A5 JP 2007506434A5
Authority
JP
Japan
Prior art keywords
virus
seneca valley
mutant
sequence
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006528260A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007506434A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/031504 external-priority patent/WO2005030139A2/en
Publication of JP2007506434A publication Critical patent/JP2007506434A/ja
Publication of JP2007506434A5 publication Critical patent/JP2007506434A5/ja
Pending legal-status Critical Current

Links

JP2006528260A 2003-09-26 2004-09-23 SenecaValleyウイルスベースの組成物および疾患の処置方法 Pending JP2007506434A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50618203P 2003-09-26 2003-09-26
PCT/US2004/031504 WO2005030139A2 (en) 2003-09-26 2004-09-23 Seneca valley virus based compositions and methods for treating disease

Publications (2)

Publication Number Publication Date
JP2007506434A JP2007506434A (ja) 2007-03-22
JP2007506434A5 true JP2007506434A5 (https=) 2007-10-18

Family

ID=34393123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006528260A Pending JP2007506434A (ja) 2003-09-26 2004-09-23 SenecaValleyウイルスベースの組成物および疾患の処置方法

Country Status (12)

Country Link
EP (1) EP1668025B1 (https=)
JP (1) JP2007506434A (https=)
KR (1) KR20060103890A (https=)
CN (1) CN1875028B (https=)
AU (1) AU2004275832A1 (https=)
BR (1) BRPI0414810A (https=)
CA (1) CA2540177A1 (https=)
DK (1) DK1668025T3 (https=)
IL (1) IL174430A0 (https=)
MX (1) MXPA06003318A (https=)
SG (1) SG149069A1 (https=)
WO (1) WO2005030139A2 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ425699A0 (en) 1999-11-25 1999-12-23 University Of Newcastle Research Associates Limited, The A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
AU2002953436A0 (en) 2002-12-18 2003-01-09 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
US7638318B2 (en) * 2003-09-26 2009-12-29 Norvartis Ag Seneca Valley virus based compositions and methods for treating disease
WO2007047256A2 (en) * 2005-10-13 2007-04-26 Neotropix, Inc. Svv-based animal vaccines and uses thereof
CN108601802A (zh) 2015-12-02 2018-09-28 纪念斯隆-凯特林癌症中心 塞尼卡谷病毒(svv)细胞受体靶向的肿瘤治疗
CN105925728B (zh) * 2016-06-01 2019-09-20 华南农业大学 一种塞内加谷病毒实时荧光定量pcr检测引物及试剂盒
US10323069B2 (en) * 2016-08-23 2019-06-18 Regents Of The University Of Minnesota Senecavirus A antigens and methods of use
AU2018301701A1 (en) * 2017-07-14 2020-02-27 Elevatebio Technologies, Inc. Encapsulated polynucleotides and methods of use
CN109627293B (zh) * 2017-08-13 2021-02-09 中牧实业股份有限公司 塞尼卡谷病毒结构蛋白抗原表位多肽及其应用
CN107513524B (zh) * 2017-09-30 2021-02-09 中牧实业股份有限公司 一株猪塞内加谷病毒毒株及其应用
CN108467904B (zh) * 2018-05-24 2021-11-19 华南农业大学 检测塞尼卡谷病毒的rt-lamp引物组、试剂盒及应用
CN109182278B (zh) * 2018-10-12 2021-08-06 河南省动物疫病预防控制中心 塞尼卡谷病毒毒株及其应用
EP3880812A4 (en) * 2018-11-13 2022-09-07 Oncorus, Inc. ENCAPSULATED POLYNUCLEOTIDES AND METHODS OF USE
CN109234464A (zh) * 2018-11-23 2019-01-18 山东新希望六和集团有限公司 用于检测塞尼卡谷病毒的引物及探针、荧光定量pcr试剂盒及方法和应用
CN111733144A (zh) * 2019-03-25 2020-10-02 金宇保灵生物药品有限公司 一种塞内卡病毒的纯化方法及病毒液的浓缩纯化方法
CN112433049B (zh) * 2019-06-24 2023-08-18 中国动物疫病预防控制中心(农业农村部屠宰技术中心) 检测塞内卡病毒抗体的试剂及其应用
AU2020315800A1 (en) 2019-07-19 2022-03-03 Seneca Therapeutics, Inc. Second generation seneca valley virus oncolytic therapy: compositions and methods thereof
CN110923211A (zh) * 2019-12-25 2020-03-27 哈药集团生物疫苗有限公司 塞内卡病毒分离株、塞内卡病毒病灭活疫苗及其制备方法
CN111286491A (zh) * 2020-02-03 2020-06-16 河南省动物疫病预防控制中心 猪塞内卡病毒核酸标准物及其应用
CN111849925B (zh) * 2020-07-06 2022-06-03 马忠仁 一种抗结肠癌疫苗及其制法
CN111798712B (zh) * 2020-07-15 2021-10-29 周晓庆 噬菌体侵染细菌3d智能模拟方法
CN111944764A (zh) * 2020-08-31 2020-11-17 信阳农林学院 一种表达猪塞内加谷病毒蛋白的细胞系、构建方法和应用
CN112390861A (zh) * 2020-09-30 2021-02-23 信阳农林学院 表达猪塞内加谷病毒vp1蛋白的细胞系、构建方法和应用
CN117281824B (zh) * 2023-08-11 2025-10-21 华南农业大学 Trim基因的过表达剂在制备抑制猪塞内卡病毒复制的产品中的应用
CN117487006B (zh) * 2023-12-29 2024-04-12 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 一种抗a型塞内卡病毒的单克隆抗体以及抗原表位及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia

Similar Documents

Publication Publication Date Title
JP2007506434A5 (https=)
Bello et al. Diagnostic and vaccination approaches for Newcastle disease virus in poultry: The current and emerging perspectives
Combelas et al. Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence
Wilton et al. Effect of formaldehyde inactivation on poliovirus
Chang et al. Merkel cell carcinoma: a virus-induced human cancer
Gromeier et al. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence
Jiang et al. Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication
DeJesus et al. Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence
Bergmann et al. The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response
CN1875028B (zh) 基于 Seneca Valley 病毒的组合物以及疾病的治疗方法
JP2008533988A5 (https=)
Brown et al. Cell-dependent role for the poliovirus 3′ noncoding region in positive-strand RNA synthesis
JP2008533988A (ja) セネカバレーウイルスを基盤とする組成物及び疾患を治療する方法
Wetzel et al. Efficiency of viral entry determines the capacity of murine erythroleukemia cells to support persistent infections by mammalian reoviruses
Zade et al. Biased selection of propagation-related TUPs from phage display peptide libraries
Kajigaya et al. Isolation and characterization of defective-interfering particles of poliovirus Sabin 1 strain
Cross et al. Use of an aberrant polypeptide as a marker in three-factor crosses: further evidence for independent reassortment as the mechanism of recombination between temperature-sensitive mutants of reovirus type 3
Leser et al. VP1 is the primary determinant of neuropathogenesis in a mouse model of enterovirus D68 acute flaccid myelitis
Sun et al. Sequence and analysis of genomic segment A and B of very virulent infectious bursal disease virus isolated from China
Riller et al. Protective role of antibodies in enteric virus infections: Lessons from primary and secondary immune deficiencies
JP2015527343A (ja) 薬物送達タンパク質の輸送向上変異体の単離
Liu et al. Identification and Genome Characterization of a Novel Muscovy Duck‐Origin Goose Parvovirus with Three Recombinant Regions between Muscovy Duck Parvovirus and Goose Parvovirus
Sadiq et al. Whole Genome Analysis of Selected Human Group A Rotavirus strains revealed evolution of DS-1-Like single-and double-gene reassortant rotavirus strains in Pakistan during 2015–2016
Bakhshinejad et al. On the origin of non-specific binders isolated in the selection of phage display peptide libraries
US20100278863A1 (en) Reoviruses